Stonepine Capital Management, LLC

Position in BIOA — BioAge Labs, Inc.

CIK 1440771 BEND, OR

Back to BIOA Full portfolio

Position in BIOA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$874,500

+$279,150 QoQ

Shares Held

50,000

+11.1% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Stonepine Capital Management, LLC holds $10,499,486 across 4 Drug Manufacturers - Specialty & Generic names. BIOA ranks #3 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EOLS	Evolus, Inc.	1,759,091	$7,229,864
2	AYTU	Aytu Biopharma, Inc	792,289	$2,162,948
3	BIOA	BioAge Labs, Inc. This page	50,000	$874,500
4	XERS	Xeris Biopharma Holdings, Inc.	40,030	$232,174

All Filings in BIOA

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$874,500	50,000	+11.1%	Shares	Sole	2026-05-14
2025-12-31	$595,350	45,000	-76.1%	Shares	Sole	2026-02-13
2025-09-30	$1,108,797	188,571	+24.8%	Shares	Sole	2025-11-13
2025-06-30	$623,981	151,085	+202.2%	Shares	Sole	2025-08-13
2025-03-31	$188,000	50,000	—	Shares	Sole	2025-05-14
No filing history on record for this holder in this stock.